Search PubMed⌕ Search

Biomedical subjects

T Kino

Publications and source records attributed to T Kino.

At least 91 records · Page 5Linked to original sources
PubMed1985

Activation of tumoricidal properties in macrophages and inhibition of experimentally-induced murine metastases by a new synthetic acyltripeptide, FK-565.

The effect of FK-565, a novel low molecular weight (MW) acyltripeptide, on tumoricidal properties of murine macrophages is reported here. Peritoneal macrophages (PMs) harvested from C57BL/6 mice and beige mice were rendered cytotoxic to syngeneic B16 melanoma cells following their interaction in vitro with FK-565. Maximal and reproducible activation of tumoricidal properties in PM were obtained by interaction in vitro with 25 micrograms/ml of FK-565 for a 24 h period, and as little as 0.5 microgram/ml of FK-565 was sufficient to induce significant cytotoxicity. Murine PMs activated by FK-565 in vitro were cytotoxic to syngeneic and xenogeneic tumor cells, but did not affect allogeneic nontumor cells. The PMs were also activated to kill B16 melanoma cells by intraperitoneal injections of FK-565 (10 mg/kg). Multiple injections of FK-565 into mice also slightly but significantly inhibited lung metastases. These results suggest that FK-565 has potential as an effective immunopotentiator in immunotherapy.

Adjuvants, Immunologic↗
PubMed1983

Antitumor effects of novel immunoactive peptides, FK-156 and its synthetic derivatives.

Effects produced by intratumor or systemic application of FK-156 and its synthetic derivatives on the syngeneic P388-DBA/2 mouse system were investigated. Among 21 compounds tested, FK-156, FK-565, FR-46758, FR-48217, FR-46091 and FR-47920 substantially suppressed tumor growth when directly injected into a tumor mass and further experiments showed that FK-156, FK-565 and FR-46758 were effective even when administered subcutaneously into site remote from tumor. The mechanisms of growth inhibition are strongly suggested to be host mediated, because these three compounds have remarkably low cytotoxicity against P388 cells in vitro. A single dose of FK-565, however, markedly decreased body weight in healthy DBA/2 mice, whereas FK-156 and FR-46758 did not. These results indicate the superiority of FK-156 and FR-46758 as immunotherapeutic agents over FK-565 with respect to their safety for treatment of cancer. Although significant life-span prolongation could not be seen in the two-injection regimen of six compounds in either system, systemic multiple injections of FK-156 and FR-46758 provided a statistically significant increase in the median survival time of P388 tumor bearing mice.

Adjuvants, Immunologic↗
PubMed1982

Studies on a new immunoactive peptide, FK-156. II. Fermentation, extraction and chemical and biological characterization.

An interesting immunoactive peptide, FK-156, has been isolated from the fermentation broth of Streptomyces olivaceogriseus sp. nov. and Streptomyces violaceus. The compound was purified by column chromatography with activated carbon, ion exchange Sephadex and cellulose powder. FK-156, obtained as white powder, exhibits a wide variety of immunostimulatory activity in vivo and in vitro with experimental animals. Pretreatment of mice or rats with this peptide protected the animals against lethal infection with Escherichia coli and resulted in prolongation of life span of tumor bearing animals.

Adjuvants, Immunologic↗
PubMed1978

Allergy to insects in Japan. I. The reaginic sensitivity to moth and butterfly in patients with bronchial asthma.

A high frequency of reaginic sensitivity to moth and butterfly extracts was shown in 66 randomly selected patients with bronchial asthma. Thirty-seven (56.1%) of these 66 patients showed positive intradermal reactions to 1:10,000 dilution of moth allergen and 34 patients (51.5%) had positive reactions to 1:10,000 butterfly allergen. These positive responses were as frequent as those to Candida or house dust which are recognized as the most commonly reactive allergens in Japan. Radioallergosorbent tests (RAST) showed that 20 of 66 sera were positive to moth and 22 sera were positive to butterfly, which indicates that about 1/3 of patients with bronchial asthma had specific IgE to moth and butterfly in the sera. Bronchial testing revealed that skin reaction-positive and RAST-positive patients were commonly provoked by specific allergen but skin reaction-negative and RAST-negative patients were not. These data suggest that moth and butterfly emanations could cause allergy-induced bronchial asthma in certain patients. Since moths are attracted readily to artificial lights and often fly into houses, these insects are especially suspect as important factors in extrinsic asthma.

Adolescent↗